{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:41:56Z","timestamp":1794004916115,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12692-x","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T06:02:36Z","timestamp":1722492156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term evaluation of the safety of a rectal-prostate spacer, the ProSpace\u00ae balloon, in patients treated with radiotherapy for prostate cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"G.","family":"Janoray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brugui\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mazurier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dudouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guillotreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tollon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Labarthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Latorzeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"issue":"1\u20132","key":"12692_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.canrad.2021.11.017","volume":"26","author":"R de Crevoisier","year":"2022","unstructured":"de Crevoisier R, Supiot S, Cr\u00e9hange G, Pommier P, Latorzeff I, Chapet O, et al. External radiotherapy for prostatic cancers. Cancer Radioth\u00e9r. 2022;26(1\u20132):329\u201343.","journal-title":"Cancer Radioth\u00e9r"},{"key":"12692_CR2","unstructured":"Urofrance | Recommandations fran\u00e7aises du Comit\u00e9 de canc\u00e9rologie de l\u2019AFU \u2013 actualisation 2020\u20132022\u202f: cancer de la prostate \u2013 Urofrance. Disponible sur: https:\/\/www.urofrance.org\/recommandation\/recommandations-francaises-du-comite-de-cancerologie-de-lafu-actualisation-2020-2022-cancer-de-la-prostate\/. Cit\u00e9 18 mai 2022"},{"issue":"4","key":"12692_CR3","first-page":"219","volume":"1","author":"A D\u2019Amico","year":"1993","unstructured":"D\u2019Amico A, Altschuler M, Whittington R, Kao G, Malkowicz SB, Wein A. The use of clinical parameters in an interactive statistical package to predict pathological features associated with local failure after radical prostatectomy for prostate cancer. Clin Perform Qual Health Care. 1993;1(4):219\u201322.","journal-title":"Clin Perform Qual Health Care"},{"issue":"17","key":"12692_CR4","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","volume":"388","author":"FC Hamdy","year":"2023","unstructured":"Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2023;388(17):1547\u201358.","journal-title":"N Engl J Med"},{"issue":"5","key":"12692_CR5","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","volume":"53","author":"A Pollack","year":"2002","unstructured":"Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53(5):1097\u2013105.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"12692_CR6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","volume":"80","author":"V Beckendorf","year":"2011","unstructured":"Beckendorf V, Guerif S, Pris\u00e9 EL, Cosset JM, Bougnoux A, Chauvet B, et al. 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial. Int J Radiat Oncol Biol Phys. 2011;80(4):1056\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"12692_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1470-2045(14)70040-3","volume":"15","author":"DP Dearnaley","year":"2014","unstructured":"Dearnaley DP, Jovic G, Syndikus I, Khoo V, Cowan RA, Graham JD, et al. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2014;15(4):464\u201373.","journal-title":"Lancet Oncol"},{"issue":"4","key":"12692_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0360-3016(97)00458-6","volume":"39","author":"C Burman","year":"1997","unstructured":"Burman C, Chui CS, Kutcher G, Leibel S, Zelefsky M, LoSasso T, et al. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1997;39(4):863\u201373.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"12692_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(SICI)1522-712X(1995)1:2<113::AID-IGS7>3.0.CO;2-D","volume":"1","author":"J Troccaz","year":"1995","unstructured":"Troccaz J, Laieb N, Vassal P, Menguy Y, Cinquin P, Bolla M, et al. Patient setup optimization for external conformal radiotherapy. J Image Guid Surg. 1995;1(2):113\u201320.","journal-title":"J Image Guid Surg"},{"issue":"1","key":"12692_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0167-8140(95)01613-L","volume":"37","author":"JM Crook","year":"1995","unstructured":"Crook JM, Raymond Y, Salhani D, Yang H, Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol J Eur Soc Ther Radiol Oncol. 1995;37(1):35\u201342.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"4","key":"12692_CR11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.ijrobp.2005.03.035","volume":"62","author":"D L\u00e9tourneau","year":"2005","unstructured":"L\u00e9tourneau D, Martinez AA, Lockman D, Yan D, Vargas C, Ivaldi G, et al. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys. 2005;62(4):1239\u201346.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12692_CR12","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.canrad.2016.07.034","volume":"20","author":"R de Crevoisier","year":"2016","unstructured":"de Crevoisier R, Chauvet B, Barillot I, Lafond C, Mah\u00e9 M, Delpon G. Radioth\u00e9rapie guid\u00e9e par l\u2019image. Cancer Radioth\u00e9r. 2016;20:S27-35.","journal-title":"Cancer Radioth\u00e9r"},{"issue":"3","key":"12692_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jjco\/hyz171","volume":"50","author":"M Ogita","year":"2020","unstructured":"Ogita M, Yamashita H, Sawayanagi S, Takahashi W, Nakagawa K. Efficacy of a hydrogel spacer in three-dimensional conformal radiation therapy for prostate cancer. Jpn J Clin Oncol. 2020;50(3):303\u20139.","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"12692_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","volume":"92","author":"N Mariados","year":"2015","unstructured":"Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, et al. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015;92(5):971\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"12692_CR15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","volume":"97","author":"DA Hamstra","year":"2017","unstructured":"Hamstra DA, Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, et al. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. Int J Radiat Oncol Biol Phys. 2017;97(5):976\u201385.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"12692_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijrobp.2014.06.044","volume":"90","author":"G Mok","year":"2014","unstructured":"Mok G, Benz E, Vallee JP, Miralbell R, Zilli T. Optimization of radiation therapy techniques for prostate cancer with prostate-rectum spacers: a systematic review. Int J Radiat Oncol Biol Phys. 2014;90(2):278\u201388.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"12692_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijrobp.2013.10.039","volume":"88","author":"O Chapet","year":"2014","unstructured":"Chapet O, Udrescu C, Tanguy R, Ruffion A, Fenoglietto P, Sotton MP, et al. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2014;88(2):425\u201332.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"12692_CR18","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.juro.2008.11.010","volume":"181","author":"R Ben-Yosef","year":"2009","unstructured":"Ben-Yosef R, Paz A, Levy Y, Alani S, Muncher Y, Shohat S, et al. A novel device for protecting rectum during prostate cancer irradiation: in vivo data on a large mammal model. J Urol mars. 2009;181(3):1401\u20136.","journal-title":"J Urol mars"},{"key":"12692_CR19","doi-asserted-by":"crossref","unstructured":"Vanneste BGL, Beek K van D, Lutgens L, Lambin P. Implantation of a biodegradable rectum balloon implant: Tips, Tricks and Pitfalls. Int Braz J Urol Off J Braz Soc Urol. 2017;43(6):1033\u201142.","DOI":"10.1590\/s1677-5538.ibju.2016.0494"},{"key":"12692_CR20","unstructured":"International Commission on Radiation Units and Measurements. ICRU report 50: prescribing, recording, and reporting photon beam therapy. 1993. Disponible sur: http:\/\/www.icru.org\/home\/reports\/prescribing-recording-and-reporting-photon-beam-therapy-report-50"},{"key":"12692_CR21","unstructured":"ICRU Report 83, Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT) \u2013 ICRU. Disponible sur: https:\/\/www.icru.org\/report\/prescribing-recording-and-reporting-intensity-modulated-photon-beam-therapy-imrticru-report-83\/. Cit\u00e9 19 mai 2022"},{"issue":"3","key":"12692_CR22","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","volume":"83","author":"HA Gay","year":"2012","unstructured":"Gay HA, Barthold HJ, O\u2019Meara E, Bosch WR, Naqa IE, Al-Lozi R, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012;83(3):e353-62.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12692_CR23","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.canrad.2016.07.032","volume":"20","author":"G No\u00ebl","year":"2016","unstructured":"No\u00ebl G, Antoni D, Barillot I, Chauvet B. D\u00e9lin\u00e9ation des organes \u00e0 risque et contraintes dosim\u00e9triques. Cancer Radioth\u00e9r. 2016;20:S36-60.","journal-title":"Cancer Radioth\u00e9r"},{"issue":"6","key":"12692_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1159\/000511647","volume":"28","author":"S Barros","year":"2021","unstructured":"Barros S, Roseira J, Caldeira P, Vaz AM, Guerreiro H, Codon O. Rectal perforation by a balloon spacer: a rare cause of rectal perforation addressed endoscopically. GE - Port J Gastroenterol. 2021;28(6):416\u20139.","journal-title":"GE - Port J Gastroenterol"},{"key":"12692_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13014-019-1248-6","volume":"14","author":"A Sch\u00f6rghofer","year":"2019","unstructured":"Sch\u00f6rghofer A, Drerup M, Kunit T, Lusuardi L, Holzinger J, Karner J, et al. Rectum-spacer related acute toxicity \u2013 endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers. Radiat Oncol Lond Engl. 2019;14:47.","journal-title":"Radiat Oncol Lond Engl"},{"issue":"1","key":"12692_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13014-020-01622-3","volume":"15","author":"F Cuccia","year":"2020","unstructured":"Cuccia F, Mazzola R, Nicosia L, Figlia V, Giaj-Levra N, Ricchetti F, et al. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy. Radiat Oncol Lond Engl. 2020;15(1):178.","journal-title":"Radiat Oncol Lond Engl"},{"issue":"1126","key":"12692_CR27","doi-asserted-by":"publisher","first-page":"20210521","DOI":"10.1259\/bjr.20210521","volume":"94","author":"R Mazzola","year":"2021","unstructured":"Mazzola R, Sicignano G, Cuccia F, Vitale C, Rigo M, Giaj-Levra N, et al. Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer. Br J Radiol. 2021;94(1126):20210521.","journal-title":"Br J Radiol"},{"issue":"3","key":"12692_CR28","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ijrobp.2013.01.036","volume":"86","author":"DA Hamstra","year":"2013","unstructured":"Hamstra DA, Conlon ASC, Daignault S, Dunn RL, Sandler HM, Hembroff AL, et al. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. Int J Radiat Oncol Biol Phys. 2013;86(3):546\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"12692_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.radonc.2014.01.007","volume":"110","author":"MH Stenmark","year":"2014","unstructured":"Stenmark MH, Conlon ASC, Johnson S, Daignault S, Litzenberg D, Marsh R, et al. Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2014;110(2):291\u20137.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"7","key":"12692_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1200\/JCO.20.02873","volume":"39","author":"LGW Kerkmeijer","year":"2021","unstructured":"Kerkmeijer LGW, Groen VH, Pos FJ, Haustermans K, Monninkhof EM, Smeenk RJ, et al. Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial. J Clin Oncol Off J Am Soc Clin Oncol. 2021;39(7):787\u201396.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"20","key":"12692_CR31","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","volume":"34","author":"WR Lee","year":"2016","unstructured":"Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, et al. Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34(20):2325\u201332.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"12692_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14338\/IJPT-16-00006.1","volume":"3","author":"TJ Pugh","year":"2016","unstructured":"Pugh TJ, Choi S, Nogueras-Gonzalaez GM, Nguyen QN, Mahmood U, Frank SJ, et al. Proton beam therapy for localized prostate cancer: results from a prospective quality-of-life trial. Int J Part Ther. 2016;3(1):27\u201336.","journal-title":"Int J Part Ther"},{"issue":"8","key":"12692_CR33","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","volume":"17","author":"D Dearnaley","year":"2016","unstructured":"Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17(8):1047\u201360.","journal-title":"Lancet Oncol"},{"issue":"2","key":"12692_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.radonc.2013.08.030","volume":"109","author":"CR King","year":"2013","unstructured":"King CR, Freeman D, Kaplan I, Fuller D, Bolzicco G, Collins S, et al.\u00a0Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2013;109(2):217\u201321.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"8","key":"12692_CR35","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/cncr.27911","volume":"119","author":"WJ Morris","year":"2013","unstructured":"Morris WJ, Keyes M, Spadinger I, Kwan W, Liu M, McKenzie M, et al. Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer. Cancer. 2013;119(8):1537\u201346.","journal-title":"Cancer"},{"issue":"4","key":"12692_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ijrobp.2015.10.011","volume":"94","author":"MS Jawad","year":"2016","unstructured":"Jawad MS, Dilworth JT, Gustafson GS, Ye H, Wallace M, Martinez A, et al. Outcomes Associated With 3 Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016;94(4):657\u201366.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"12692_CR37","doi-asserted-by":"publisher","first-page":"e795","DOI":"10.1016\/j.ijrobp.2011.11.040","volume":"82","author":"CA Lawton","year":"2012","unstructured":"Lawton CA, Yan Y, Lee WR, Gillin M, Firat S, Baikadi M, et al. Long-term results of an RTOG Phase II trial (00\u201319) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2012;82(5):e795-801.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"12692_CR38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.brachy.2016.05.001","volume":"15","author":"PF Orio","year":"2016","unstructured":"Orio PF, Nguyen PL, Buzurovic I, Cail DW, Chen YW. The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness. Brachytherapy. 2016;15(6):701\u20136.","journal-title":"Brachytherapy"},{"issue":"7","key":"12692_CR39","first-page":"644","volume":"25","author":"B Hoppe","year":"2011","unstructured":"Hoppe B, Henderson R, Mendenhall WM, Nichols RC, Li Z, Mendenhall NP. Proton therapy for prostate cancer. Oncol Williston Park N. 2011;25(7):644\u201350 652.","journal-title":"Oncol Williston Park N."},{"issue":"3","key":"12692_CR40","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ijrobp.2014.03.012","volume":"89","author":"DWN Kim","year":"2014","unstructured":"Kim DWN, Cho LC, Straka C, Christie A, Lotan Y, Pistenmaa D, et al. Predictors of Rectal Tolerance Observed in a Dose-Escalated Phase 1\u20132 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer. Int J Radiat Oncol juill. 2014;89(3):509\u201317.","journal-title":"Int J Radiat Oncol juill"},{"key":"12692_CR41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejca.2016.02.014","volume":"59","author":"R Hannan","year":"2016","unstructured":"Hannan R, Tumati V, Xie XJ, Cho LC, Kavanagh BD, Brindle J, et al. Stereotactic body radiation therapy for low and intermediate risk prostate cancer\u2014Results from a multi-institutional clinical trial. Eur J Cancer. 2016;59:142\u201351.","journal-title":"Eur J Cancer"},{"key":"12692_CR42","doi-asserted-by":"publisher","first-page":"701998","DOI":"10.3389\/fonc.2021.701998","volume":"11","author":"I Latorzeff","year":"2021","unstructured":"Latorzeff I, Brugui\u00e8re E, Bogart E, Le Deley MC, Lartigau E, Marre D, et al. Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study. Front Oncol. 2021;11:701998.","journal-title":"Front Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12692-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12692-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12692-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T06:03:17Z","timestamp":1722492197000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12692-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12692"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12692-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3330542\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the experimental protocol was approved by the SFRO committee (French Society of Radiation Oncology). All patients obtained written information about the study objectives and gave their written informed consent prior to balloon placement.Consent for patients\/participants to publish their identifiable information: Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"I confirm that I understand BMC Cancer is an open access journal that levies an article processing charge per articles accepted for publication. By submitting my article, I agree to pay this charge in full if my article is accepted for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"934"}}